Study guide

13.2 LV and LA Size, Geometry, Volumes, Mass, and Function

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

13.2 LV and LA Size, Geometry, Volumes, Mass, and Function

Key Takeaways Explain This Topic AI

Nonforeshortened apical planes, defined end-diastolic and end-systolic frames, valid endocardial borders, and representative beats precede every LV or LA calculation.

Biplane disks or high-quality 3-D data quantify LV volumes; index size to BSA and preserve method, loading, rhythm, and image quality when comparing serial studies.

LV geometry combines sex-specific indexed mass with RWT, while EF and strain remain loading-, method-, and image-quality dependent measures of function.

Maximal LA volume is traced just before mitral opening, excludes pulmonary veins and appendage, and is indexed to BSA; enlargement reflects chronic context rather than instantaneous pressure alone.

Last updated: July 2026

Start with reproducible planes and cardiac timing

Chamber quantification is only as valid as the plane that created it. Record blood pressure, heart rate, rhythm, height, and weight; calculate body surface area for indexed measures. Acquire nonforeshortened apical four- and two-chamber views with the LV apex at the sector's far field and the long axis centered. The apex should not appear rounded, and the long-axis lengths from the two apical views should be similar. Move the transducer rather than merely steering a foreshortened image. Foreshortening underestimates volumes and can distort ejection fraction.

Measure at defined times. LV end-diastole is the frame at mitral closure or the largest cavity, and end-systole is at aortic closure or the smallest cavity. Use ECG and valve motion when timing is unclear. In sinus rhythm, average representative beats according to laboratory protocol; irregular rhythm requires more beats and selection with similar preceding cycle lengths. Avoid postectopic beats. Loading, heart rate, rhythm, ventilation, and blood pressure can change size and function without structural progression, so preserve them for serial comparison.

Quantify LV size, volume, and ejection

Measure Recommended approach Major limitation

LV linear dimensions 2-D-guided parasternal long-axis plane, perpendicular to long axis at mitral leaflet tips Oblique cuts exaggerate diameter; a single dimension misses asymmetric remodeling

EDV and ESV Biplane method of disks from nonforeshortened apical four- and two-chamber contours Poor border, apical truncation, and inconsistent basal closure alter every disk

3-D volumes Full-volume dataset with complete LV and adequate temporal resolution Stitching, dropout, vendor algorithms, and incomplete pyramids; volumes may differ by method

Ejection fraction (EDV − ESV) / EDV × 100 using the same method and valid beats Load, rhythm, border error, and geometric assumptions; EF is not contractility alone

Stroke volume EDV − ESV or validated Doppler flow calculation Small diameter error is squared in Doppler area and compounds with VTI error

For biplane volumes, trace the compacted myocardium–cavity interface at end-diastole and end-systole. Do not contour around papillary muscles or trabeculations; exclude them from the tracing so they remain part of the LV chamber or blood pool for volume calculation. Set the basal line across the mitral annular plane without including LA. When two contiguous endocardial segments are not visible, optimize frequency, gain, depth, and harmonic settings; use ultrasound-enhancing agent according to protocol rather than inventing a border. Three-dimensional volumes avoid geometric assumptions and are preferred when complete, high-quality datasets are feasible. Preserve the acquisition and analysis method because 2-D, 3-D, and contrast values are not interchangeable without context.

Index EDV and ESV to body surface area and apply the laboratory's age-, sex-, and method-specific reference ranges. For 2-D LVEF, conventional normal ranges are 52%–72% in men and 54%–74% in women. Do not describe a ventricle as normal from EF alone: report size, geometry, regional wall motion, global function, and, when indicated, cardiac output and myocardial deformation. EF may be preserved despite reduced longitudinal function or low stroke volume and may fall with acute afterload elevation. GLS adds sensitivity but remains vendor-, tracking-, loading-, and image-quality dependent; use the same platform and convention for serial work.

Calculate LV mass and define geometry

Measure interventricular septum, LV internal diameter, and posterior wall at end-diastole from a perpendicular parasternal long-axis plane. The cube formula magnifies small errors, so off-axis measurement, inclusion of RV trabeculation, or misplacement beyond the compact myocardium can substantially change mass. Index mass to BSA and use sex-specific limits; conventional upper normal LV mass index is 115 g/m² for men and 95 g/m² for women. Relative wall thickness, or RWT, is 2 × posterior wall thickness / LV internal diameter at end-diastole ; RWT greater than 0.42 is increased.

  • LV mass index RWT Geometry
  • Normal ≤0.42 Normal geometry
  • Normal >0.42 Concentric remodeling
  • Increased >0.42 Concentric hypertrophy
  • Increased ≤0.42 Eccentric hypertrophy

Geometry describes remodeling, not its cause. Hypertension, valve disease, athletic adaptation, infiltrative disease, and loading can overlap, and wall thickness is not synonymous with mass. Review image quality, clinical setting, and serial pattern before assigning physiology.

Measure LA volume rather than relying on one diameter

The LA is asymmetric, so an anteroposterior linear diameter can miss enlargement. Measure maximal LA volume at ventricular end-systole, immediately before mitral opening, from dedicated nonforeshortened apical four- and two-chamber views. Trace the blood-tissue boundary, exclude pulmonary veins and the LA appendage, and close the contour across the mitral annulus. Use biplane disks when both views are valid and index volume to BSA. A conventional LAVI of 34 mL/m² or less is normal; 35–41 is mildly, 42–48 moderately, and greater than 48 severely enlarged.

LA enlargement often reflects cumulative exposure to elevated filling pressure, mitral disease, or AF, but it is not a direct instantaneous pressure measurement. Acute pressure elevation may occur before dilation, while athletic remodeling, high output, obesity, and chronic AF can enlarge the LA through different pathways. Indexing to BSA can also mask obesity-related enlargement. Interpret LA volume with Doppler filling evidence, valve disease, rhythm, and clinical context. Report the method, indexed result, and image limitation. Serial conclusions are strongest when planes, beats, border convention, and analysis platform match.

Confirm unexpected serial change

Verify plane, timing, border, beat selection, loading, and analysis method before labeling an unexpected numerical difference as true remodeling.

Reacquire a foreshortened apex

If one apical long axis is visibly shorter or the apex is rounded, move the transducer to expose the true apex before tracing. A precise contour cannot repair a truncated ventricle or atrium, and numerical reproducibility does not rescue a systematically biased plane.